Publications Xianjin Luo

• Luo X, Weidinger E, Burghardt T, Höhn M, Wagner E (2025) CRISPR/Cas9 Ribonucleoprotein Delivery Enhanced by Lipo-Xenopeptide Carriers and Homology-Directed Repair Modulators: Insights from Reporter Cell Lines, Int J Mol Sci. 2025 May 3;26(9):4361

• Luo X, Germer J, Burghardt T, Grau M, Lin Y, Höhn M, Lächelt U, Wagner E (2025) Dual pH-responsive CRISPR/Cas9 ribonucleoprotein xenopeptide complexes for genome editing,  Eur J Pharm Sci. 2025 Feb 1;205:106983

• Shen, F., Lin, Y., Höhn, M., Luo, X., Döblinger, M., Wagner, E., Lächelt, U. (2023) Iron-gallic acid peptide nanoparticles as versatile platform for cellular delivery with synergistic ROS enhancement effect, Pharmaceutics 2023 Jun 21;15(7):1789
• LinY., Luo, X., Burghardt, T., Dörrer, S., Höhn, M., Wagner, E., Lächelt, U. (2023) Chemical evolution of amphiphilic xenopeptides for potentiated Cas9 ribonucleoprotein delivery, J Am Chem Soc. 2023 Jul 19;145(28):15171-15179
• Lin Y, Wilk U, Pöhmerer J, Hörterer E, Höhn M, Luo X, Mai H, Wagner E, Lächelt U. (2023) Folate receptor-mediated delivery of Cas9 RNP for enhanced immune checkpoint disruption in cancer cells, Small. 2023 Jan;19(2):e2205318